Information was received from a consumer via manufacturer representative regarding a patient receiving morphine 2mg/ml for a total dose of 0.2001mg/day via an implantable pump for non-malignant pain.It was reported the patient had an increase in post implant pain and swelling.The patient had a computed tomography (ct) scan, a catheter dye study, and was seen in the emergency room (er) a couple of times regarding pain in abdominal area.The pump and catheter were explanted on (b)(6) 2017 and will not be returned for analysis.Cultures of pump pocket site were sent to pathology.Surgical intervention occurred as the patient was seen in the er on (b)(6) 2017 for possible pump site infection.The patient was discharged and referred to neurosurgery for a pocket revision.Upon opening the pump pocket site, it was noted that the patient had an active infection and the decision was made to completely explant both the pump and the catheter.It was noted that the issue was resolved at time of report, and the patient's status at time of report was "alive-no injury." the patient's weight was 103kg.The patient's medical history was asked, but unknown.Event date was (b)(6) 2017.No further complications were reported/anticipated.
|